Litcius/Paper detail

Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3

David D. Bushart, Annie J. Zalon, Hongjiu Zhang, Logan M Morrison, Yuanfang Guan, Henry L. Paulson, Vikram G. Shakkottai, Hayley S. McLoughlin

2020The Cerebellum26 citationsDOIOpen Access PDF

Topics & Concepts

Spinocerebellar ataxiaNeurosciencePurkinje cellMotor neuronCerebellumBiologyAtaxiaCerebellar ataxiaMachado–Joseph diseaseDeep cerebellar nucleiCerebellar cortexSpinal cordGenetic Neurodegenerative DiseasesMitochondrial Function and PathologyIon channel regulation and function
Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3 | Litcius